December 21, 1998

BUSINESS CONCENTRATES: 11

CAPITAL SPENDING: 13

C&EN poll of chemical firms finds spending on new plants and equipment projected to drop in 1998.

FINE CHEMICALS: 17

Pharmaceutical ingredients producers highlighted new products, capacity at annual exhibition.

POLYCARBONATES: 20

Producers are adding capacity to meet forecast rise in global demand.

COOLING WATER: 21

Two companies find ways around persistent treatment problem.

December 14, 1998

BUSINESS CONCENTRATES: 19

COVER STORY

DUPONT'S CHAD HOLLIDAY: 21

New CEO bucks chemical industry trend by aggressively growing both chemical and life sciences businesses.

UNIQEMA: 25

ICI combines five groups to form single specialty chemicals operation.

December 7, 1998

BUSINESS CONCENTRATES: 23

SINGLE-SITE CATALYSTS: 25

Specialty chemical producers bring their technical strengths to a lucrative market.

BIOMASS ETHANOL: 29

New wave of companies takes on the challenges of commercial production of alternative fuel.

BUSINESS INSIGHTS: 33

Where's the science in environmental groups' campaign to ban soft vinyl toys?

November 30, 1998

BUSINESS CONCENTRATES: 10

SEPRACOR: 11

"Improved chemical entity" versions of established drugs are key to young company's growth.

HEDGING PRICES: 14

Option trading can minimize price volatility in commodity chemicals.

DEGUSSA-H$ULS: 15

New firm will have leading market position in a number of specialty chemicals.

November 23,1998

BUSINESS CONCENTRATES: 15

COVER STORY: LIFE SCIENCES: 17

Corporate landscape is being transformed as chemical companies embrace biotech.

CHLORINE INDUSTRY: 26

Pact on environmental practices is signed by several unions and producers, but not some key players.

INTERPHARMA: 27

A revitalized Czech specialties firm seeks partners for global growth.

November 16, 1998

BUSINESS CONCENTRATES: 12

CHEMICAL EARNINGS: 15

Drops in demand and pricing, effects of Asian economic crisis drive down third-quarter earnings.

DRUG FIRM EARNINGS: 20

Healthy product sales swell the bottom line of pharmaceutical companies.

November 9, 1998

BUSINESS CONCENTRATES: 17

COVER STORY

BIOCIDES: 21

Producers project strong growth despite increasing regulation.

BRAIN CANCER AT AMOCO:42

Cluster of rare tumors is not directly linked to workplace, but company responds quickly to the crisis.

METHYL BROMIDE:46

Congress grants four-year reprieve for ozone-depleting pesticide.

TEXTILE CHEMICALS:49

Increased trade among North American countries helps keep U.S. demand up.

November 2, 1998

BUSINESS CONCENTRATES: 11

COST REDUCTIONS:13

Chemical firms are lowering costs of technical purchasing to gain competitive advantage.

BUSINESS INSIGHTS:15

Consolidation is the mantra of chemical companies, but it's easier said than done.

October 26, 1998

BUSINESS CONCENTRATES: 13

COVER STORY: RESPONSIBLE CARE:15

Third-party verification of CMA member companies' ethical work codes is a good step, but needs tweaking.

PROGNOSIS FOR EUROPE:21

Chemical marketing group sees restructured producers in good shape for uncertain future.

MALAYSIA:23

Economic controls are having little effect on chemical industry--for now.

October 19, 1998

BUSINESS CONCENTRATES: 25

BIOINFORMATICS: 29

The pharmaceutical industry copes with flood of information.

SCI ANNUAL CONFERENCE: 34

Company executives predict tough times, further restructuring of chemical industry in Europe.

October 12, 1998

BUSINESS CONCENTRATES: 21

BASF'S STRATEGY:23

Expansions and new plants capitalize on total integration to increase U.S. chemical division sales.

SCI MEDALIST:26

DuPont's Edgar Woolard is recognized for outstanding business leadership and environmental stewardship.

October 5, 1998

BUSINESS CONCENTRATES: 13

PLASTICS DOWNTURN:15

Asian crisis and overcapacity are pressuring commodity plastics prices, with no relief expected anytime soon.

NEW DRUG LEADS:25

Dutch firm scours the world for researchers' collections of compounds.

BUSINESS INSIGHTS:26

A more proactive chemical industry and effort to increase scientific literacy could help overcome negative public opinion.

September 28, 1998

NESS

BUSINESS CONCENTRATES: 13

ELEMENTIS: 15

British company that used to be Harrisons & Crosfield has a new focus on chemicals.

SMUGGLING IN CHINA:17

Government crackdown has limited and short-lived effect.

LENZING:18

After two years of losses, Austrian fiber producer reports profits in first-half 1998.

September 21, 1998

BUSINESS CONCENTRATES: 17

RESEARCH PARTNERSHIPS: 21

Universities welcome industry support of research, but not its expectation of rights to intellectual property.

INTERNATIONAL ISOTOPES: 27

Radioisotope producer looks to fill niche in U.S. market.

STRATEGIC PLANNING: 30

Companies adopt military strategies to boost their competitiveness.

September 14, 1998

BUSINESS CONCENTRATES: 13

COVER STORY

ASHLAND CHEMICAL:15

Distributor and producer of chemicals marches to its own beat.

DOW POLYURETHANES: 19

New applications may drive capacity expansion.

KOREAN CHEMICALS:20

Industry restructuring with foreign investment.

September 7, 1998

BUSINESS CONCENTRATES: 15

HARNESSING CHLORINE: 17

Chlorine links Gulf Coast chemical producers.

SYNTHETIC LUBRICANTS: 21

Demand is rising for formulations that provide greater reliability and stability.

August 31, 1998

BUSINESS CONCENTRATES: 10

COVER STORY: FIBERS: 12

Producers struggle with effects of Asian fiber glut, changing demand.

August 24, 1998

BUSINESS CONCENTRATES: 29

ASIAN FINANCIAL CRISIS: 31

Strong U.S. and European firms remain committed to the region.

MEMBRANE MATERIALS: 38

Demand will grow steadily for next five years, according to report.

EUROPEAN EARNINGS: 40

Most chemical producers had a good first half in 1998.

SWEDEN'S AGA: 42

To raise its stature, industrial gases firm is restructuring, expanding markets.

August 17, 1998

BUSINESS CONCENTRATES: 10

CHEMICAL EARNINGS: 12

Despite difficult economic conditions, 30 major producers report only 4% drop in earnings for the second quarter.

PHARMACEUTICAL EARNINGS:16

Sales of new products drive earnings growth for leading drug and biotech companies.

REPLACING HCFC-141b: 18

Drop-in substitute for foam blowing agent is elusive, but the phaseout deadline nears.

August 10, 1998

BUSINESS CONCENTRATES: 15

COVER STORY

BIOPHARMACEUTICALS: 19

Bringing any pharmaceutical to market is difficult, but biotechnology industry expects success from new drug therapies.

LET'S MAKE A DEAL: 32

Merger and acquisition activity is very high in the chemical industry.

CHEMICAL HINDSIGHTS: 37

CNN/Time nerve gas story did not meet basic standards of journalism.

This file updated July 8, 2008